MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

antihypertensive therapy

Search medical newsFind research, conditions and clinical updates
  • Home
  • antihypertensive therapy
Escalating Antihypertensive Therapy in Early-Onset Severe Preeclampsia: Dynamic Marker of Maternal Risk During Expectant Management
Posted inInternal Medicine news OB/GYN & Women’s Health

Escalating Antihypertensive Therapy in Early-Onset Severe Preeclampsia: Dynamic Marker of Maternal Risk During Expectant Management

Posted by By MedXY 09/23/2026
Escalation of antihypertensive treatment in expectant management of early-onset preeclampsia with severe features correlates with increased maternal adverse outcomes, suggesting treatment trajectory as a dynamic risk indicator.
Read More
Accelerating Care in Intracerebral Hemorrhage: The Impact of Mobile Stroke Units
Posted inEmergency Medicine Neurology news

Accelerating Care in Intracerebral Hemorrhage: The Impact of Mobile Stroke Units

Posted by By MedXY 07/05/2026
Mobile Stroke Units enable faster diagnosis and initiation of antihypertensive treatment in intracerebral hemorrhage, significantly reducing time to care compared with conventional EMS transportation.
Read More
Quadpill or Dual Therapy for hypertension? Emerging Consensus After QUARTET — What Clinicians and Patients Should Know
Posted inCardiology Internal Medicine news

Quadpill or Dual Therapy for hypertension? Emerging Consensus After QUARTET — What Clinicians and Patients Should Know

Posted by By MedXY 11/14/2025
Summarizes emerging expert consensus on ultra‑low‑dose quadruple antihypertensive therapy (the “quadpill”) after QUARTET and related evidence, with practical recommendations and caveats for clinical use.
Read More
Optimizing Nifedipine GITS Dosing in Severe Preeclampsia: Daily 60 mg versus 30 mg BID – Evidence from a Randomized Controlled Trial
Posted inClinical Updates news OB/GYN & Women's Health

Optimizing Nifedipine GITS Dosing in Severe Preeclampsia: Daily 60 mg versus 30 mg BID – Evidence from a Randomized Controlled Trial

Posted by By MedXY 09/19/2025
This RCT compares nifedipine GITS 30 mg twice daily versus 60 mg once daily in severe preeclampsia, finding similar blood pressure control but fewer emergent treatments with twice-daily dosing, informing safer antihypertensive strategies in pregnancy.
Read More
Reevaluating Antihypertensive Therapy in Frail Elderly Nursing Home Residents: Insights from the RETREAT-FRAIL Trial
Posted inCardiology news Specialties

Reevaluating Antihypertensive Therapy in Frail Elderly Nursing Home Residents: Insights from the RETREAT-FRAIL Trial

Posted by By MedXY 08/30/2025
The RETREAT-FRAIL trial found no survival benefit from progressively reducing antihypertensive medications in frail nursing home residents aged ≥80 with controlled blood pressure, supporting individualized treatment strategies.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Targeting ANGPTL4 with MAR001: A Promising Approach for Reducing Elevated Triglycerides
  • Enhancing Muscle Endurance: The Impact of Superimposed Tendon Vibration on Isometric Knee Extension Fatigue
  • Enhancing Reactive Balance in Incomplete Spinal Cord Injury: Evaluating the Impact of Functional Electrical Stimulation Combined with Reactive Balance Training
  • Assessing Risks and Safety in Pediatric Dental Sedation: Insights from Claims Data Analysis (2014-2019)
  • Pathotype-Specific Gene Expression Illuminates Genetic Susceptibility in Early Rheumatoid Arthritis
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top